Rick Simpson Oil (RSO) in Texas: The Complete Guide

When folks across Texas first hear about Rick Simpson Oil, they usually come to us with the same mixture of hope and skepticism. Maybe you’ve watched someone you love struggle through chemotherapy, searching for anything that might help with the nausea. Maybe you’ve dealt with chronic pain that no prescription could touch, or sleepless nights that left you desperate. Or maybe you’re simply tired of the hype-filled CBD products cluttering convenience store shelves across Dallas, Houston, Austin, and San Antonio, and you want something real.

We get it. We’ve been there ourselves.

We’re OilWell Cannabis, and we’ve spent years developing what we believe is the most scientifically grounded, accessible, and honest Rick Simpson Oil formula available to Texas residents today. This guide exists to give you everything we wish we’d known when we started — the history of RSO, the science behind the cannabinoids, the legal framework that makes our products accessible without a medical card, and thecomplete formula we publish openly so you can decide for yourself.

Because here’s the truth: we’re not trying to sell you snake oil. We’re trying to give you the best possible version of this information so you can make your own decision about whether it’s right for you.

What Is Rick Simpson Oil?

Rick Simpson Oil refers to a concentrated cannabis extract that originated with a Canadian man named Rick Simpson in the early 2000s. But in 2025, the term “RSO” gets thrown around a lot, and it means different things to different people. Let us clear up what RSO actually is, where it came from, and why that history matters for anyone in Texas considering these products today.

Who Is Rick Simpson?

Rick Simpson was born in 1949 in Amherst, Nova Scotia, Canada. He wasn’t a doctor. He wasn’t a scientist. He was a power engineer and maintenance worker — a blue-collar tradesman who found his way into cannabis advocacy through personal suffering and a deep frustration with a medical system that had failed him.

In 1997, Simpson suffered a serious head injury when he fell from scaffolding while working at a hospital in New Brunswick. The aftermath was brutal: persistent tinnitus, dizziness, and post-concussion symptoms that conventional medicine couldn’t resolve. According to Simpson, the medications he was prescribed either didn’t work or made things worse. When he asked his doctor about cannabis, the request was refused.

Simpson’s interest in concentrated cannabis intensified after he learned about a 1974 study from the Medical College of Virginia, funded by the National Institutes of Health, where THC was reported to slow or shrink tumors in mice. That study — originally designed to demonstrate harm — became a touchstone for Simpson, even though its findings were never replicated in human cancer trials.

Then came 2003. Simpson reported that three bumps on his arm were diagnosed as basal cell carcinoma. Rather than pursuing conventional treatment, he applied concentrated cannabis oil directly to the lesions. According to his account, they disappeared within days. No independent medical verification exists. No biopsy confirmation. No clinical follow-up published in any peer-reviewed source.

And yet, that personal experience became the origin of everything that followed.

Important context: Simpson’s account is his personal testimony. Without clinical documentation or independent confirmation, we can’t evaluate it as medical evidence. But we can acknowledge what it became: the catalyst for a global movement.

How RSO Spread Across the World

After 2003, Simpson committed himself fully to making cannabis oil and giving it away for free to anyone who asked. He charged nothing. By his own account, he helped people dealing with cancer, chronic pain, diabetes, infections, glaucoma, arthritis, depression, and insomnia.

His story went global through the 2005 documentary Run From The Cure, which was distributed freely online. Within cannabis communities worldwide, that film was foundational. For many people, it was their first introduction to concentrated cannabis oil as something other than a recreational substance.

Simpson’s advocacy put him directly in conflict with Canadian law. The RCMP raided his property in 2005 and again in 2009. He was charged with cultivation, possession, and trafficking. Facing continued legal pressure, Simpson eventually left Canada for Europe.

Throughout his public career, Simpson maintained an unwavering position: he believed cannabis oil could cure cancer and many other diseases, and that pharmaceutical companies and government agencies were suppressing this knowledge. He framed his work as a fight against institutional corruption.

Important context: We present Simpson’s worldview without endorsing or dismissing it. It reflects a perspective shared by many in the early cannabis movement. Our job isn’t to pick sides — it’s to give you the evidence so you can decide.

The Original RSO Protocol — What Simpson Recommended

Simpson developed a specific treatment protocol: 60 grams of concentrated cannabis oil consumed over approximately 90 days. The titration schedule started small — about half a grain of rice, three times daily — and gradually increased to roughly 1 gram per day by week five.

At peak dosing, patients were consuming roughly 600 to 900 milligrams of THC daily. For context, FDA-approved synthetic THC (dronabinol) is typically prescribed at 2.5 to 20 milligrams per day. The gap between Simpson’s protocol and anything clinically studied is enormous.

Simpson recommended oral ingestion as the primary method, topical application for skin conditions, and acknowledged inhalation only for immediate symptom relief. He believed patients would develop tolerance within three to four weeks and urged them not to let psychoactive effects discourage them.

Critical safety context: This protocol was designed around crude, unstandardized extract with no quality control. No controlled clinical trial has ever validated the 60-gram protocol for any condition. The THC exposure levels far exceed anything studied in human research. We urge anyone considering high-dose cannabinoid therapy to work with their healthcare provider, not to replace medical treatment with cannabis oil.

What Traditional RSO Actually Was

Traditional RSO was defined by Simpson’s method, not by lab specifications:

• Source material: Single high-THC indica strain, no standardization
• Extraction solvent: Naphtha or isopropyl alcohol — neither food-grade
• Process: Cannabis washed with solvent, evaporated in a rice cooker, collected as thick dark oil
• Appearance: Nearly black, tar-like, with possible solvent-residual odor
• Cannabinoid profile: Fully decarboxylated THC, estimated 60-90% potency, never lab-verified
• Terpene content: Destroyed by solvent and heat
• Testing: None — every batch was different

The safety concerns with traditional RSO production are significant. Naphtha is a petroleum-based solvent that may contain benzene, toluene, and other toxic compounds. Incomplete solvent purging — which is very difficult to verify without lab testing — leaves potentially harmful residues.

This is the product that became legendary. And this is what we evolved from.

What the Evidence Actually Says About RSO Claims

We need to be completely honest with you about what science supports and what it doesn’t. Simpson made expansive claims about RSO curing cancer and many other diseases. Let’s look at the evidence record.

What Simpson Was Not

Simpson had no formal training in medicine, oncology, pharmacology, or clinical research. He never designed, conducted, or published a clinical trial. His evidence consisted entirely of personal experience and testimonials — no controls, no independent verification, no peer review.

What the Preclinical Literature Shows

Real science does exist in this space:

• In vitro studies have shown THC and CBD can induce apoptosis (cell death), inhibit proliferation, and reduce angiogenesis in certain cancer cell lines
• Animal studies have demonstrated some tumor-growth inhibition in mice and rats treated with cannabinoids
• These findings have generated legitimate scientific interest and ongoing research

What the Preclinical Literature Does NOT Show

• These findings have not translated into proven human cancer cures
• The gap between lab results and human outcomes is vast
• No human clinical trial has demonstrated that RSO or any cannabis oil preparation cures cancer
• Small trials in glioblastoma and other cancers have been exploratory, not curative

What Major Health Institutions Say

• National Cancer Institute: Acknowledges cannabinoid anticancer research but does not endorse cannabis as cancer treatment
• FDA: Has not approved any cannabis plant product for cancer treatment
• NCCIH: States strongest evidence is for rare epilepsies, chemotherapy nausea, and HIV/AIDS appetite stimulation — not cancer cure

What Simpson Got Right

Simpson drew attention to cannabinoids as a serious biomedical research area when most of the world was ignoring it. His advocacy helped create conditions for legal cannabis and cannabinoid research infrastructure. The term “RSO” remains the most recognized name for full-spectrum cannabis extract in consumer vocabulary.

What He Overstated

The leap from preclinical signals to cancer cure claims was not supported by evidence then, and it isn’t now. Encouraging patients — especially cancer patients — to use RSO in place of proven treatments carries genuine harm potential. Delayed or foregone treatment for treatable cancers is documented in the alternative medicine literature.

Who We Are and Why We Built This Differently

OilWell Cannabis was founded by Colin Valencia in Houston. Colin grew up in McAllen, Texas, right across from Reynosa — one of the most challenging regions along the U.S.-Mexico border. His childhood involved exposure to violence, lost friends, and hard choices. By sixteen, he was on his own.

Colin chose cannabis over darker paths. He learned the plant intimately in the traditional cannabis world, long before legalization. Eventually, he became a formally trained software engineer and did custom development work for Baylor College of Medicine in the Texas Medical Center — a combination of deep plant knowledge and medical-grade technical precision that would define OilWell’s approach.

Our Origin Story — It Started With a Dog Named Bentley

Bentley was more than a pet. He was family. When veterinarians said Bentley needed to be euthanized due to paralysis and organ-damaging pain medications, Colin refused to give up.

A rescue worker named Jessica asked him something that changed everything: “You’ve moved how many tons of weed and you’ve never heard of CBD?”

Colin had cannabis experience — but it was recreational. Therapeutic applications were completely unknown to him. Determined to save Bentley, he learned to create CBD golden paste. And Bentley got up. He walked over and brought his ball to play. From paralyzed and facing euthanasia to fetching — in a way that no placebo effect could explain.

Bentley lived another ten years, passing naturally at age twenty. During those years, Colin developed specialized formulas for every condition Bentley faced:

• Neurodegeneration → CBG’s neuroprotective properties and THCa’s PPARγ agonism
• Dementia → CBC’s role in neurogenesis
• Glaucoma → THC’s CB1 agonism for intraocular pressure
• Arthritis → Multi-pathway anti-inflammatory approaches

Single cannabinoids weren’t enough. Bentley’s evolving conditions required multi-cannabinoid synergy. Pharmaceutical precision mattered because Bentley’s life depended on it.

Colin’s Personal Experience With PTSD and Pharmaceutical Dependence

Colin doesn’t just formulate these products — he uses them. He’s struggled with PTSD and benzodiazepine addiction. When he decided to break free from Xanax, he did it cold turkey using the cannabinoid knowledge he’d developed. Our Peace Gummies formula was created during midnight experiments while fighting through benzo withdrawal.

This isn’t theoretical. Colin lives what RSO patients live: desperation for relief, failed pharmaceuticals, the discovery that cannabinoids work when pills don’t.

Our Media Recognition — Something We’re Proud Of

ABC13 Houston — the ABC affiliate in America’s fourth-largest city — has featured Colin and OilWell Cannabis in seven comprehensive news segments spanning 2019 to 2023. Five different reporters sought us out across those years: Tom Abrahams, Steve Campion, Shelley Childers, Nick Natario, and KTRK staff.

When ABC13 needed to explain Delta-8 to Houston, they called Colin. When Texas banned Delta-8 overnight, they came to our dispensary. When President Biden announced marijuana pardons, they interviewed Colin — revealing something personal: Colin has himself faced marijuana possession charges. He knows firsthand the consequences of cannabis criminalization.

In September 2019, Colin said something on ABC13 that captures our entire philosophy:

“I’m not trying to sell people snake oil. I’m not trying to sell people hope. But there’s enough research out there that people just need to know and try and have the best possible version to base their opinions off of to give it a fair shot as to whether it’s right or wrong for them.”

That’s what this guide is. The best possible version of the information.

Our RSO Philosophy — How We Evolved From Tradition

Our RSO isn’t traditional Rick Simpson Oil. It’s informed by the tradition but deliberately different in specific, evidence-motivated ways.

Four Core Principles

1. Accessibility Over Gatekeeping

No medical card required. If you’re 21 or older, you can purchase. We ship nationwide and internationally to customers who verify local legality.

Simpson believed medicine should be accessible; we built a legal product and distribution model that makes that accessible.

2. Patient-Controlled Potency

THCa is sold in its acidic, non-psychoactive form. You decide whether to use it raw for non-psychoactive benefits or to decarboxylate it into delta-9 THC for full psychoactive potency.

Simpson believed patients should control their own medicine; we engineered a product that puts that control in your hands through chemistry.

3. Open-Source Formulas

We publish our complete formulas — every cannabinoid, every milligram, every percentage. If you can’t afford our products, you can see exactly what’s in them, source ingredients, and make your own.

Simpson gave his oil away and taught people how to make it; we adapted that ethos for the modern marketplace.

4. Evidence-Informed, Not Evidence-Overstating

We distinguish between what’s well-supported by human clinical data, what’s emerging from research, and what’s overstated relative to evidence.

Simpson operated without access to the peer-reviewed literature we have today; we use it and hold ourselves to the same standards we apply to everyone else.

How Our Formula Differs From Traditional RSO

Dimension	Traditional RSO	Our Formulated RSO
Source material	Single high-THC indica strain	Multi-cannabinoid blend from multiple sources
Extraction	Naphtha or isopropyl alcohol	Modern food-grade ethanol or CO₂ methods
Cannabinoid profile	THC-dominant, uncontrolled	Seven defined cannabinoids at specific ratios
Terpene content	Destroyed by heat	Live terpenes at 5% with defined profile
Standardization	None — every batch different	Lab-tested with specific mg/mL targets
Testing	Not available	Full panel testing with COAs
Residual solvents	Significant risk	Controlled and tested
THCa preservation	No — fully decarboxylated	Yes — 1,500mg preserved
Delta-9 THC	60-90% estimated	90mg total in entire bottle
Formats	Single thick oil	Sublingual oil and vape cartridge

Why Multiple Cannabinoids Matter

Traditional RSO relied on whatever single strain was available. Our formulas intentionally include seven cannabinoids because the entourage-effect literature suggests potential benefit from cannabinoid diversity, even though robust clinical proof of whole-formula synergy remains limited.

Why Terpenes Matter

Traditional RSO destroyed terpenes through solvent extraction and high-heat evaporation. We include live terpenes at 5% because terpene bioactivity is plausible and supported at the preclinical level — antimicrobial, anti-inflammatory, anxiolytic — even if human clinical confirmation for cannabis-specific terpene effects is still developing.

Why We Preserve THCa

Traditional RSO fully decarboxylated everything. We include THCa at 1,500mg as a distinct ingredient because THCa literature suggests potentially relevant non-psychoactive bioactivity — anti-inflammatory activity via COX-2 inhibition, neuroprotective potential via PPARγ agonism — that’s lost when THCa converts to THC.

The Legal Framework — How We Made This Accessible to Texans

Here’s what makes our product available without a medical card in Texas and most states.

Farm Bill Compliance

The 2018 Farm Bill legalized hemp and hemp-derived products containing less than 0.3% delta-9 THC by dry weight. Our sublingual oil contains only 90mg of delta-9 THC in the entire 30mL bottle — that’s 3mg per milliliter, well under the legal threshold.

All cannabinoids in our formula are hemp-derived. The product is legal under federal law and in most states.

The THCa Legal Innovation

THCa is the acidic, non-psychoactive precursor to delta-9 THC. It’s not delta-9 THC. This distinction is legally significant: THCa is Farm Bill compliant at the point of sale because it hasn’t been converted.

What does this mean for you?

You can purchase our product legally. Then, if you choose, you can decarboxylate the THCa into delta-9 THC at home by heating the oil at 260°F for 45-60 minutes. This converts 1,500mg of THCa into approximately 1,315mg of delta-9 THC. Combined with the existing 90mg, that’s roughly 1,405mg of total delta-9 THC — psychoactive potency comparable to traditional RSO, entirely at your discretion after purchase.

The same legal product can function as:

• Non-psychoactive anti-inflammatory (used raw)
• Full-potency psychoactive cannabinoid product (after home decarboxylation)

Important legal notice: You are responsible for understanding and complying with your local laws. We ship with full documentation, COAs, and receipts. International customers accept all customs and legal responsibility.

The Decarboxylation Choice — You Control Potency

Traditional RSO was always fully decarboxylated. Patients had no choice about psychoactivity — the oil was always psychoactive.

Our sublingual formula contains THCa in its acidic, non-psychoactive form. This creates three distinct usage options:

Option 1: Raw, No Heat

All 1,500mg stays as THCa — completely non-psychoactive. This is compatible with work, driving, and daytime use with zero impairment. Research suggests potential anti-inflammatory activity and neuroprotective effects.

Option 2: Fully Activated, Home Decarboxylation

Heat the oil at 260°F for 45-60 minutes in an oven-safe glass container. This converts THCa into delta-9 THC. Combined with the existing delta-9 and delta-8 THC in the formula, you achieve psychoactive potency comparable to traditional high-THC RSO.

You can also transfer a portion to a separate container and decarboxylate only what you intend to use, preserving the rest in raw form.

Option 3: Vape — Auto-Decarboxylation

Our vape cartridge vaporizes at 400-450°F, which instantly converts THCa to delta-9 THC with each inhalation. Every puff delivers freshly decarboxylated cannabinoids — the fastest-onset delivery method available.

The conversion chemistry: 1mg THCa = approximately 0.877mg delta-9 THC after decarboxylation (reflecting the loss of a CO₂ molecule).

Our Complete Formula — Open Source

We publish everything. Here’s exactly what’s in our products.

RSO Sublingual Oil — $129.99

Cannabinoid	Amount
CBD	4,500mg
CBG	3,000mg
Delta-8 THC	6,000mg
THCa	1,500mg
Delta-9 THC	90mg
CBN	750mg
CBC	750mg
Total Cannabinoids	16,590mg

• Live Terpenes: 5%
• Format: 30mL bottle with graduated dropper
• Active cannabinoids per mL: 553mg
• Onset: 15-45 minutes (sublingual absorption)
• Peak effects: 1-2 hours
• Duration: 4-6 hours
• Bioavailability: 13-19% (sublingual route partially bypasses first-pass metabolism)

RSO Vape Cartridge — $49.99

Cannabinoid	Percentage
CBD	30%
CBG	20%
Delta-8 THC	15%
THCa	10%
CBN	10%
CBC	10%

• Live Terpenes: 5%+
• Format: 1-gram cartridge, 510-thread compatible
• Onset: 1-2 minutes
• Peak effects: 10-15 minutes
• Duration: 2-4 hours
• Automatic THCa decarboxylation at vaping temperature

Terpene Profile (Both Products)

• Limonene — citrus-bright, potential mood elevation
• Myrcene — relaxation
• Caryophyllene — pepper/spice, selective CB2 receptor agonist
• Pinene — forest-fresh, cognitive clarity
• Linalool — floral/lavender, calming properties
• Humulene — earthy/woody, potential anti-inflammatory
• Terpinolene — piney/fruity, complexity

The Science Behind Each Cannabinoid

We believe you deserve to understand what the research actually says — not just marketing claims.

CBD (4,500mg in sublingual formula)

Evidence profile: CBD has the strongest human evidence of any compound in our formula.

What’s well supported:

• Certain rare seizure disorders (FDA-approved Epidiolex)
• Anxiety: A 2024 systematic review covering 316 participants found statistically significant anxiolytic effects, though authors emphasized the clinical sample remains limited

What’s emerging:

• Pain: A 2024 systematic review found promising but heterogeneous results, with trial quality limiting confidence
• Sleep: Research remains methodologically weak with non-validated measures

Safety considerations:

• Drug interactions (CBD affects liver enzymes that metabolize many medications)
• Possible liver enzyme elevation in some contexts
• Diarrhea, sleepiness, appetite changes
• Always consult your healthcare provider about interactions

CBG (3,000mg in sublingual formula)

Evidence profile: Mostly review-level and preclinical; human evidence remains sparse.

Pharmacology: CBG is the biosynthetic precursor to several major cannabinoids. It interacts with cannabinoid receptors, alpha-2 adrenoceptors, and 5-HT1A-related signaling.

Potential research areas: Review literature discusses possible relevance to neurologic disorders, inflammatory bowel disease, and antibacterial activity — but these are hypotheses, not established indications.

Bottom line: CBG is scientifically interesting and commercially available precisely because it’s underexplored. We include it for potential synergistic benefit, but claims shouldn’t outrun the science.

Delta-8 THC (6,000mg in sublingual formula)

Evidence profile: Pharmacologically relevant, psychoactive, much less clinically characterized than delta-9 THC.

What we know:

• Delta-8 and delta-9 THC have broadly similar pharmacokinetic and pharmacodynamic behavior
• Delta-8 is a partial CB1 agonist with cannabimimetic activity
• It appears less potent than delta-9 THC, likely due to weaker CB1 affinity

Public health concerns:

• Much of the evidence base is animal studies, product chemistry, and use reports
• Manufacturing quality varies widely across the market
• Adverse event reports exist

Our approach: We use pharmaceutical-grade delta-8 from verified sources, lab-tested for purity. But don’t assume it’s weak or trivial — it’s genuinely psychoactive.

THCa (1,500mg in sublingual formula)

Evidence profile: Important chemically and formulation-wise, but low on direct human therapeutic evidence.

Key distinctions:

• THCa is the acidic precursor to THC
• THCa itself does not produce psychoactive effects
• That distinction only holds if it stays in acidic form and isn’t substantially decarboxylated

Research status: In vitro and rodent literature suggest anti-inflammatory, immunomodulatory, neuroprotective, and antineoplastic possibilities — but these aren’t established human outcomes.

Critical point: Any claim about THCa needs to account for possible conversion to THC through heating or over time.

Delta-9 THC (90mg total in sublingual formula)

Evidence profile: Strongest human evidence of psychoactive cannabinoids, but also clearest adverse-effect burden.

What’s institutionally supported:

• Chemotherapy-related nausea and vomiting
• Appetite stimulation in HIV/AIDS
• Some multiple sclerosis symptoms
• Modest evidence for chronic pain

Safety considerations:

• Impairment and motor vehicle crash risk
• Anxiety or panic at high doses
• Tachycardia and blood pressure changes
• Cannabis use disorder risk
• Psychiatric concerns in vulnerable individuals
• Pregnancy concerns
• Drug testing implications

Our approach: We use minimal delta-9 THC (90mg total in the entire bottle) specifically to keep psychoactive effects manageable while still capturing therapeutic potential. Most psychoactive effect comes from delta-8 THC and activated THCa when you choose to decarboxylate.

CBN (750mg in sublingual formula)

Evidence profile: Weak human evidence; marketing has clearly moved ahead of data.

What it’s marketed for: Sleep and sedation.

What the research shows: A 2021 narrative review on CBN and sleep screened 99 human-study abstracts and found no clinical trials using validated sleep questionnaires or formal polysomnography that could substantiate strong sleep-promoting claims.

Why we include it: While direct clinical evidence is limited, CBN is a natural degradation product of THC and contributes to the full-spectrum profile. The 750mg dose means you can experiment with what works for you — but don’t believe anyone who claims it’s “clinically proven” for sleep.

CBC (750mg in sublingual formula)

Evidence profile: Emerging, intriguing, still overwhelmingly preclinical.

What research shows:

• Distinct pharmacodynamics and receptor behavior relative to better-known cannabinoids
• Antinociceptive, antibacterial, and anti-seizure interest in research
• Anti-inflammatory effects and neurobiological relevance in preclinical work

Important context: CBC products are already being sold despite little evidence establishing clinical efficacy. We include it for potential synergistic benefit, not as a standalone treatment.

The Science Behind Our Terpenes

Terpene claims require even stricter interpretation than cannabinoid claims. Much of the literature comes from isolated compounds, essential oils, non-cannabis plants, or preclinical models. But here’s what we know:

Limonene

Evidence profile: Largely review and preclinical.

Potential activity: Antioxidant, anti-inflammatory, cardioprotective, gastroprotective, immune-modulatory. Research suggests mood-elevating properties.

Safety note: Limonene oxidation products are clinically relevant contact allergens.

Myrcene

Evidence profile: Mostly preclinical, limited human evidence.

Common claim: “Couch-lock” sedating terpene.

Reality: Myrcene has plausible anxiolytic and analgesic properties in preclinical work, but human clinical confirmation is lacking.

Caryophyllene — The Standout

Evidence profile: Mechanistically interesting due to direct cannabinoid-system relevance.

Why it matters: Beta-caryophyllene is a selective CB2 receptor agonist. This makes it especially relevant for anti-inflammatory and immunomodulatory effects.

Research themes: Anti-inflammatory, antioxidant, neuroprotective, gastroprotective actions are discussed in review literature.

Pinene

Evidence profile: Promising preclinical, weak human clinical.

Potential: Antioxidant, anti-inflammatory, and neuroprotective signals. The cognition-enhancing claims remain hypothetical.

Linalool

Evidence profile: Substantial preclinical interest, limited direct clinical confirmation.

Research: Discussed for stress, mood, and neuropharmacologic relevance. Oxidized linalool is a recognized allergen.

Humulene

Evidence profile: Translationally interesting, early.

Findings: A 2024 scoping review found broad preclinical evidence for anti-inflammatory effects, with some rodent work suggesting cannabimimetic properties.

Terpinolene

Evidence profile: One of the least clinically characterized terpenes.

Status: Has biological effects in preclinical work but remains underdeveloped clinically.

When to Use Each Format

Use Case	Recommended Format	Why
Fast relief (acute pain, nausea, panic)	Vape	1-2 minute onset
Sustained relief (chronic pain, sleep)	Sublingual	4-6 hour duration
Maximum bioavailability	Sublingual	13-19% absorption
Portability and discretion	Vape	Compact, no measuring
Precise dosing control	Sublingual	Graduated dropper
Daytime non-psychoactive use	Sublingual (raw)	THCa inactive, zero impairment
Nighttime psychoactive use	Sublingual (decarbed) or Vape	Activated THCa + delta-8

Condition-Specific Usage Context

Important disclaimer: The following usage contexts are informed by cannabinoid research. They are not medical prescriptions, not FDA-approved protocols, and not substitutes for professional medical care. Our products have not been evaluated by the FDA and are not intended to diagnose, treat, cure, or prevent any disease. Always consult a qualified healthcare provider.

Chemotherapy-Related Nausea and Appetite Support

• Pre-chemo: 0.5 to 1.0 mL sublingual approximately 1 hour before treatment
• Acute breakthrough nausea: 2-3 vape puffs for immediate relief
• Post-chemo: 0.5 mL sublingual every 6 hours as needed
• Sleep support during treatment: 1.0 to 2.0 mL sublingual before bed

Evidence context: Delta-8 THC antiemetic evidence, delta-9 THC nausea evidence, CBD anxiolytic effects.

Chronic Pain (Fibromyalgia, Arthritis, Neuropathy)

• Daytime: 0.3 to 0.5 mL raw sublingual — anti-inflammatory exposure without impairment
• Nighttime: 0.5 to 1.0 mL decarboxylated sublingual — combines pain relief with CBN for sleep
• Breakthrough pain: Vape as needed

Evidence context: CBD pain evidence, delta-9 THC pain evidence, caryophyllene CB2 agonism, THCa COX-2 inhibition.

Sleep Support

• Before bed: 1.0 to 2.0 mL sublingual
• At 2.0 mL, delivers 50mg CBN
• At 1.0 mL, delivers 25mg CBN

Evidence context: CBN sleep research is limited but the dose levels align with what some sleep literature has explored.

Anxiety and Stress

• Daytime functional relief: 0.3 mL raw sublingual — CBD and CBG address anxiety pathways without impairment
• Nighttime: 1.0 mL sublingual — full profile including CBN

Evidence context: CBD anxiety evidence, CBG pharmacology, limonene entourage effect.

General Titration Principle

Start low, go slow. Begin with 0.25 to 0.5 mL sublingual and assess effects over 2-3 hours before increasing. Individual responses vary based on body weight, metabolism, tolerance, concurrent medications, and other factors.

Delivery and Accessibility for Texas Residents

We operate the only same-day RSO delivery system in Houston. And we ship statewide and beyond.

Houston Same-Day Delivery

Zone	Coverage	Delivery Fee	Turnaround
Texas Medical Center	60+ TMC institutions (MD Anderson, Memorial Hermann, Methodist, Texas Children’s, and more)	FREE	2-4 hours
Inner Loop (610)	Downtown, Midtown, Montrose, Heights, Rice Village, Museum District, River Oaks	$5	2-4 hours
Within Beltway 8	Bellaire, Memorial, Spring Branch, South Houston, Pasadena area	$10	3-5 hours
Greater Houston suburbs	Katy, Sugar Land, Pearland, Clear Lake, Woodlands, Cypress, Tomball, Humble, Kingwood	$15	4-6 hours
Extended region (60 miles)	Galveston, Baytown, Rosenberg, Conroe, La Porte	$20-25	Same-day if ordered before 2 PM

Free delivery to the Texas Medical Center — the world’s largest medical complex with over 10 million patient visits annually. This reflects our commitment to accessibility for the patients who need it most.

Texas Statewide Shipping

• USPS Priority Mail (2-3 business days)
• FedEx and UPS Ground (3-5 business days)
• Discreet packaging
• Temperature-stable packaging for Texas summers
• Tracking provided
• Signature-required option available

Whether you’re in Dallas-Fort Worth, Austin, San Antonio, El Paso, Lubbock, Corpus Christi, or anywhere in between — we ship statewide.

How We Compare to TCUP Dispensary RSO

Dimension	TCUP Dispensary RSO	Our RSO
Cannabinoids	THC-only (~420mg per 0.5g)	7 cannabinoids: CBD, CBG, delta-8, THCa, delta-9, CBN, CBC
CBG	0mg	3,000mg
CBN	0mg	750mg
CBC	0mg	750mg
Patient-controlled potency	No — always psychoactive	Yes — THCa non-psychoactive until you decide
Access	Medical card + qualifying condition	Age 21+, no card needed
Qualifying conditions	Cancer, PTSD, epilepsy, autism, terminal illness, ALS, MS, seizure disorders	None required
Delivery	Travel to dispensary	Same-day Houston, statewide shipping

If you qualify for TCUP, we support that program. But for Texans who don’t qualify — or who want a multi-cannabinoid approach with patient-controlled potency — we’re here.

Why We Publish Our Formula Openly

If you can’t afford our products, we want you to have the recipe. This isn’t marketing — it’s who we are.

The CBD golden paste formula that saved Bentley? We published it on our About Us page:

CBD Golden Paste for Pets

Ingredients:

• 1/2 cup organic turmeric powder
• 1 cup water
• 1/3 cup coconut oil (organic, unrefined)
• 1-2 teaspoons freshly ground black pepper (essential for absorption)
• CBD oil (dose depends on pet size; consult veterinarian)

Instructions:

1. Combine turmeric and water in a saucepan. Stir over low heat until thick paste forms (7-10 minutes).
2. Add coconut oil and black pepper. Mix thoroughly.
3. Cool, transfer to jar, refrigerate up to two weeks.
4. Add appropriate CBD oil dose before serving.

This is the same formula that helped Bentley get up and bring his ball to play. It’s free, it’s open-source, and it demonstrates that our commitment to accessibility isn’t new.

Quality and Safety — What We Test

• Potency: HPLC/UHPLC analysis confirms every cannabinoid to ±2% accuracy
• Heavy metals: ICP-MS testing for arsenic, cadmium, lead, mercury below FDA limits
• Pesticides: 400+ compound screening via LC-MS/MS and GC-MS/MS
• Residual solvents: FDA Class 3 limits verified by headspace GC
• Microbial: Comprehensive pathogen screening including E. coli, Salmonella, Aspergillus

COAs are available on request and through our website.

Our Broader Product Line

Beyond RSO, we offer:

Asshole Peach Gummy Rings ($39.99) — Our best-selling product. 268mg total cannabinoids per ring, favored by veterans for PTSD and pain relief.

Peace Gummy Peaches ($34.99) — Born from Colin’s benzo withdrawal experience. 320mg total cannabinoids including 30mg CBN for sleep.

SWEETEMintz Sugar-Free Vegan Peppermint Hard Candy ($39.99) — Zero sugar, 100% vegan, designed for diabetics and health-conscious consumers.

Custom Creations — We design tailored products for specific needs. Vegans, diabetics, unique cannabinoid ratios — we work with you.

Common Questions From Texas Residents

“Is this actually legal?”

Yes. Our products contain less than 0.3% delta-9 THC at point of sale. All cannabinoids are hemp-derived. Farm Bill compliant.

“Will I get in trouble?”

Not for purchasing or possessing our products as sold. What you do with THCa after purchase (decarboxylation) is your decision and your responsibility.

“What about drug tests?”

If you use psychoactive cannabinoids (delta-8, activated THCa), you will test positive for THC. THCa in raw form stays inactive — but once decarboxylated, it converts to delta-9 THC. Be honest with yourself about your situation.

“How is this different from CBD oil I see at gas stations?”

Our formula contains 16,590mg total cannabinoids across seven compounds, plus live terpenes. Most gas station CBD contains minimal cannabinoids, no terpenes, and inconsistent quality. We publish our formula; they don’t.

“Why is it expensive?”

Compare total cannabinoid content. Our bottle delivers over 16 grams of active cannabinoids. When you calculate cost-per-milligram, we’re competitive — and we’re delivering a multi-cannabinoid, terpene-rich formula with patient-controlled potency.

“Can I make this myself?”

Yes. That’s why we publish the formula.

Visit Us in Houston

Address: 810 Richmond Avenue, Houston, TX 77006 (Montrose neighborhood)

Hours:

• Monday-Thursday: 10:00 AM – 7:00 PM
• Friday-Saturday: 10:00 AM – 10:00 PM
• Sunday: 10:00 AM – 4:00 PM

Contact:

• Phone: (832) 416-2816
• Email: [email protected]
• Website: oilwellcbd.com
• Instagram: @oilwellcbd

The Bottom Line

We built OilWell Cannabis because we believe Texans deserve better than hype, better than mystery ingredients, better than products that overpromise and underdeliver.

Our RSO formula represents years of personal experience, professional development, and genuine care. Colin survived childhood violence, watched friends die or go to prison, saved his dog when veterinarians gave up, fought through PTSD and benzo withdrawal, and built a company that now serves customers across Texas and beyond.

We’re not asking you to believe cannabis will cure anything. We’re asking you to have the best possible version of the information, try it if it makes sense for you, and decide for yourself.

Because when Bentley brought that ball across the room, Colin learned something we’ve never forgotten:

Sometimes hope isn’t snake oil. Sometimes it’s chemistry, and compassion, and refusing to give up.

Welcome to OilWell Cannabis. We’re glad you’re here.

These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure, or prevent any disease. Consult your healthcare provider before using cannabinoid products, especially if you have a medical condition, take medications, are pregnant or nursing, or have health concerns. Do not drive or operate machinery while under the influence of psychoactive cannabinoids. Keep out of reach of children. Must be 21 or older to purchase.